Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Archives of Neurology

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.64.7.NCT60005PMID 17502459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.

  2005cited by this paper
• Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.

  2005cited by this paper
• Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders.

  2004influential reference
• Coenzyme Q 10 Improves Lactic Acidosis, Strokelike Episodes, and Epilepsy in a Patient With MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike episodes)

  2004cited by this paper
• MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease

  2004influential reference
• Oxidative Stress to Dopaminergic Neurons as Models of Parkinson's Disease

  2004influential reference
• Therapeutic effects of coenzyme Q10 in neurodegenerative diseases.

  2004influential reference
• Effect of coenzyme Q10 on the mitochondrial function of skin fibroblasts from Parkinson patients.

  2004influential reference
• Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.

  2004cited by this paper
• Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.

  2003cited by this paper
• The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.

  2003cited by this paper
• Coenzyme Q10 in early Parkinson disease.

  2003cited by this paper
• Placebo‐associated improvements in motor function: Comparison of subjective and objective sections of the UPDRS in early Parkinson's disease

  2002influential reference
• Coenzyme Q10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia.

  2002cited by this paper
• Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

  2002influential reference
• Coenzyme Q is an obligatory cofactor for uncoupling protein function

  2000influential reference
• [The Unified Parkinson's Disease Rating Scale].

  2000cited by this paper
• Serum levels of coenzyme Q10 in patients with Parkinson's disease

  2000cited by this paper
• Effect of coenzyme Q10 and α‐tocopherol content of mitochondria on the production of superoxide anion radicals

  2000cited by this paper
• Serum levels of coenzyme Q10 in patients with Alzheimer's disease

  2000cited by this paper
• Effect of coenzyme Q(10) and alpha-tocopherol content of mitochondria on the production of superoxide anion radicals.

  2000cited by this paper
• Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.

  1998cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

  1997cited by this paper
• Biochemical, physiological and medical aspects of ubiquinone function.

  1995influential reference
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect

  1990influential reference
• Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease

  1990influential reference
• Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10

  1988cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper

• Antioxidant and neuroprotective effects of ubiquinol diacetate: Insights from SH-SY5Y cell line and Caenorhabditis elegans models of Parkinson's disease.

  2026cites this paper
• The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective.

  2025cites this paper
• Dietary intake of coenzyme Q10 reduces oxidative stress in patients with acute ischemic stroke: a double-blind, randomized placebo-controlled study

  2025cites this paper
• Preparing for Parkinson's disease prevention trials: Current progress and future directions.

  2025cites this paper
• Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment

  2025cites this paper
• Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling

  2025cites this paper
• The effect of diet on Parkinson's disease progression, symptoms and severity: a review of randomised controlled trials.

  2025cites this paper
• Coenzyme Q10 as an adjunctive treatment for substance use disorders: a preclinical review.

  2025cites this paper
• Nutraceutical Strategies for Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases

  2025cites this paper
• Investigating the individual and combined effects of coenzyme Q10 and vitamin C on CLP-induced cardiac injury in rats

  2024cites this paper
• Unravelling the role of nutraceutical supplements in treatment of Parkinson’s Disease

  2024cites this paper
• Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review

  2024cites this paper
• A comprehensive review of natural compounds and their structure–activity relationship in Parkinson’s disease: exploring potential mechanisms

  2024cites this paper
• Therapeutic roles of coenzyme Q10 in peripheral nerve injury-induced neurosensory disturbances: Mechanistic insights from injury to recovery.

  2024cites this paper
• Effects of dietary supplements, foods, and dietary patterns in Parkinson’s disease: meta-analysis and systematic review of randomized and crossover studies

  2024cites this paper
• Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies

  2024cites this paper
• DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson’s disease

  2023cites this paper
• Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients

  2023cites this paper
• Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases

  2023cites this paper
• Mitochondrial dysfunction and neurological disorders: A narrative review and treatment overview.

  2023cites this paper
• What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson’s Disease?

  2022cites this paper
• Mitochondria research and neurodegenerative diseases: on the track to understanding the biological world of high complexity.

  2022cites this paper
• Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease

  2022cites this paper
• The Impact of Coenzyme Q10 on Neurodegeneration: a Comprehensive Review

  2022cites this paper
• Iron Brain Menace: The Involvement of Ferroptosis in Parkinson Disease

  2022cites this paper
• Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review

  2022cites this paper
• Nutraceuticals in brain health

  2021cites this paper
• Medical treatment of the motor features of Parkinson disease

  2021cites this paper
• Preventing and Treating of Parkinson’s Disease with a Plant-Based Diet

  2021cites this paper
• Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases

  2021cites this paper
• Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress

  2021cites this paper
• Neuroprotective strategies in Parkinson’s disease: A long road ahead

  2021cites this paper
• Nutrition and Lifestyle Interventions for Managing Parkinson’s Disease: A Narrative Review

  2020cites this paper
• Aging-Related Disorders and Mitochondrial Dysfunction: A Critical Review for Prospect Mitoprotective Strategies Based on Mitochondrial Nutrient Mixtures

  2020cites this paper
• The Role of Oxidative Stress in Parkinson’s Disease

  2020cites this paper
• Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

  2020cites this paper
• Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease

  2020cites this paper
• Parkinson’s Disease: Possible Mechanisms for Nutritional Approaches

  2020cites this paper
• Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease

  2020cites this paper
• Role of Dietary Supplements in the Management of Parkinson’s Disease

  2019cites this paper
• Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway

  2019cites this paper
• Organoselenotriazoles attenuate oxidative damage induced by mitochondrial dysfunction in mev-1 Caenorhabditis elegans mutants.

  2019cites this paper
• Neuroprotection in Parkinson’s disease: facts and hopes

  2019cites this paper
• Investigating metabolomics and the effects of oxyresveratrol in experimental Parkinson's disease

  2019cites this paper
• Beyond weight loss after sleeve gastrectomy: improvement in health-related quality of life

  2018cites this paper
• Coenzyme Q10 and neuropsychiatric and neurological disorders: relevance for schizophrenia

  2018cites this paper
• Genetic analysis of multiple system atrophy and related movement disorders

  2018cites this paper
• Coenzyme Q10 supplementation in acute ischemic stroke: Is it beneficial in short-term administration?

  2018cites this paper
• Effects of coenzyme Q10 supplementation on oxidative stress and antioxidant enzyme activity in glazers with occupational cadmium exposure: A randomized, double-blind, placebo-controlled crossover clinical trial

  2018cites this paper
• International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

  2018cites this paper
• Coenzyme Q10 deficiency in elderly: Can nutritional supplementation play a role? Mini review

  2018cites this paper
• Lipophilic antioxidants in neurodegenerative diseases.

  2018cites this paper
• Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson’s disease in experimental animals

  2018cites this paper
• Neuronutrition: An Emerging Concept

  2017cites this paper
• Old and new challenges in Parkinson's disease therapeutics

  2017cites this paper
• Medical Treatment of Parkinson’s Disease

  2017cites this paper
• Electron Transport Chain

  2017cites this paper
• The efficacy and safety of coenzyme Q10 in Parkinson’s disease: a meta-analysis of randomized controlled trials

  2017cites this paper
• Large-scale identification of clinical and genetic predictors of Parkinson’s disease motor progression in newly-diagnosed patients: a longitudinal cohort study and validation

  2017cites this paper
• Selenium in the Therapy of Neurological Diseases. Where is it Going?

  2016cites this paper
• Nutraceuticals against Neurodegeneration: A Mechanistic Insight

  2016cites this paper
• The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases

  2016cites this paper
• Parkinson’s Disease and Aging

  2016cites this paper
• Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease

  2016cites this paper
• Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.

  2016cites this paper
• Lithium carbonate and coenzyme Q10 reduce cell death in a cell model of Machado-Joseph disease

  2016cites this paper
• Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidants for Prevention and Improved Management of Parkinson’s Disease

  2016cites this paper
• Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases

  2015cites this paper
• CoQ₁₀ Function and Role in Heart Failure and Ischemic Heart Disease.

  2015cites this paper
• Influence of Dietary Constituents on Motor and Non-motor Symptoms in Parkinson’s Disease

  2015cites this paper
• Polymersome Mediated Delivery of Mitochondrial therapeutics to parkin Mutant Fibroblasts

  2015influential citation
• Macronutrients intake and risk of Parkinson's disease: A meta‐analysis

  2015cites this paper
• Dietary Supplements in Older Adults

  2015cites this paper
• Oxidative Stress in Neurodegenerative Diseases

  2015cites this paper
• Stimulation of electron transport as potential novel therapy in Parkinson's disease with mitochondrial dysfunction.

  2015cites this paper
• Identification of parkin interactions: implications for Parkinson’s disease

  2015cites this paper
• Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

  2015cites this paper
• Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease.

  2015cites this paper
• The Benefits of Coenzyme Q 10 as A Nutritional and Medicinal Supplement

  2015cites this paper
• Autophagy and apoptosis dysfunction in neurodegenerative disorders.

  2014cites this paper
• Current Experience in Testing Mitochondrial Nutrients in Disorders Featuring Oxidative Stress and Mitochondrial Dysfunction: Rational Design of Chemoprevention Trials

  2014cites this paper
• Parkinson’s Disease: An Overview of Etiology, Clinical Manifestations, and Treatment

  2014cites this paper
• Treatment of Mitochondrial Disorders

  2014cites this paper
• Bioenergetic medicine

  2014cites this paper
• Systemic Redox Biomarkers in Neurodegenerative Diseases.

  2014cites this paper
• The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson's Disease

  2014cites this paper
• Does High-Dose Coenzyme Q10 Improve Oxidative Damage and Clinical Outcomes in Parkinson's Disease?

  2014cites this paper
• Targeting mitochondria for neuroprotection in Parkinson disease.

  2014cites this paper
• Ursache der Parkinson-Krankheit: Braak revisited

  2014cites this paper
• Mitochondria: prospective targets for neuroprotection in Parkinson's disease.

  2014cites this paper
• A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

  2014cites this paper
• A Review of the Clinical Evidence for Complementary and Alternative Therapies in Parkinson’s Disease

  2014cites this paper
• Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.

  2014cites this paper
• Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications

  2013cites this paper
• Mitochondrial diseases of the brain.

  2013cites this paper
• Sulfhydration mediates neuroprotective actions of parkin

  2013cites this paper
• Review of Clinical Trials for Mitochondrial Disorders: 1997–2012

  2013cites this paper
• Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone

  2013cites this paper
• Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.

  2013cites this paper
• Mitochondrial Reactive Oxygen Species Promote Epidermal Differentiation and Hair Follicle Development

  2013cites this paper